Inari Selling And Marketing Expenses vs Research Development Analysis

NARI Stock

USD 48.40 1.30 2.76%

Inari Medical financial indicator trend analysis is infinitely more than just investigating Inari Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inari Medical is a good investment. Please check the relationship between Inari Medical Selling And Marketing Expenses and its Research Development accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.

Selling And Marketing Expenses vs Research Development

Selling And Marketing Expenses vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inari Medical Selling And Marketing Expenses account and Research Development. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Inari Medical's Selling And Marketing Expenses and Research Development is 0.9. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Research Development in the same time period over historical financial statements of Inari Medical, assuming nothing else is changed. The correlation between historical values of Inari Medical's Selling And Marketing Expenses and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Inari Medical are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Selling And Marketing Expenses i.e., Inari Medical's Selling And Marketing Expenses and Research Development go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Selling And Marketing Expenses

Research Development

Most indicators from Inari Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inari Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.As of now, Inari Medical's Tax Provision is increasing as compared to previous years. The Inari Medical's current Sales General And Administrative To Revenue is estimated to increase to 0.94, while Selling General Administrative is projected to decrease to under 176.5 M.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	4.5M	7.6M	10.7M	11.3M
Interest Income	154K	1.9M	15.6M	16.4M

Depreciation And Amortization Interest Income

Inari Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		0.86	0.99	0.99	0.99	0.99	0.87	-0.12	-0.3	0.92	0.53	0.9	0.85	0.47	0.74	0.75	0.92	0.82	0.93	0.74	0.46	0.94	1.0	0.89	0.92	0.81
Short Long Term Debt Total	0.86		0.84	0.85	0.91	0.91	0.87	-0.49	0.08	0.92	0.79	0.62	0.76	0.72	0.95	0.87	0.94	0.96	0.95	0.95	0.03	0.95	0.86	0.91	0.93	0.46
Other Current Liab	0.99	0.84		1.0	0.97	0.98	0.9	-0.05	-0.29	0.93	0.49	0.9	0.86	0.49	0.74	0.73	0.92	0.8	0.94	0.74	0.49	0.92	1.0	0.9	0.9	0.83
Total Current Liabilities	0.99	0.85	1.0		0.97	0.98	0.9	-0.06	-0.28	0.93	0.5	0.9	0.86	0.5	0.74	0.73	0.92	0.8	0.94	0.74	0.48	0.92	1.0	0.9	0.9	0.83
Total Stockholder Equity	0.99	0.91	0.97	0.97		1.0	0.89	-0.25	-0.2	0.92	0.64	0.83	0.8	0.49	0.78	0.83	0.95	0.88	0.95	0.78	0.32	0.97	0.98	0.92	0.95	0.71
Net Tangible Assets	0.99	0.91	0.98	0.98	1.0		0.89	-0.24	-0.21	0.92	0.63	0.84	0.8	0.49	0.78	0.82	0.95	0.88	0.95	0.78	0.33	0.97	0.99	0.92	0.95	0.72
Property Plant And Equipment Net	0.87	0.87	0.9	0.9	0.89	0.89		-0.17	-0.05	0.96	0.52	0.66	0.66	0.43	0.78	0.84	0.96	0.87	0.88	0.78	0.17	0.87	0.89	0.97	0.94	0.58
Net Debt	-0.12	-0.49	-0.05	-0.06	-0.25	-0.24	-0.17		-0.72	-0.18	-0.88	0.15	-0.01	-0.31	-0.44	-0.48	-0.27	-0.57	-0.35	-0.44	0.68	-0.44	-0.08	-0.33	-0.31	0.41
Retained Earnings	-0.3	0.08	-0.29	-0.28	-0.2	-0.21	-0.05	-0.72		-0.11	0.52	-0.47	-0.26	0.14	0.11	0.06	-0.1	0.18	0.02	0.11	-0.71	0.03	-0.3	0.06	-0.12	-0.6
Accounts Payable	0.92	0.92	0.93	0.93	0.92	0.92	0.96	-0.18	-0.11		0.54	0.76	0.8	0.55	0.87	0.77	0.99	0.91	0.93	0.87	0.29	0.9	0.92	0.97	0.96	0.67
Cash	0.53	0.79	0.49	0.5	0.64	0.63	0.52	-0.88	0.52	0.54		0.26	0.41	0.54	0.69	0.74	0.61	0.81	0.72	0.69	-0.37	0.79	0.51	0.66	0.62	0.02
Non Current Assets Total	0.9	0.62	0.9	0.9	0.83	0.84	0.66	0.15	-0.47	0.76	0.26		0.88	0.36	0.54	0.39	0.73	0.57	0.79	0.54	0.77	0.75	0.9	0.69	0.7	0.96
Non Currrent Assets Other	0.85	0.76	0.86	0.86	0.8	0.8	0.66	-0.01	-0.26	0.8	0.41	0.88		0.75	0.79	0.44	0.76	0.63	0.87	0.79	0.61	0.76	0.85	0.69	0.69	0.83
Other Assets	0.47	0.72	0.49	0.5	0.49	0.49	0.43	-0.31	0.14	0.55	0.54	0.36	0.75		0.84	0.45	0.53	0.51	0.67	0.84	0.06	0.55	0.49	0.45	0.45	0.3
Long Term Debt	0.74	0.95	0.74	0.74	0.78	0.78	0.78	-0.44	0.11	0.87	0.69	0.54	0.79	0.84		0.73	0.88	0.87	0.88	1.0	0.04	0.83	0.74	0.82	0.83	0.41
Cash And Short Term Investments	0.75	0.87	0.73	0.73	0.83	0.82	0.84	-0.48	0.06	0.77	0.74	0.39	0.44	0.45	0.73		0.84	0.86	0.77	0.73	-0.21	0.85	0.74	0.83	0.86	0.25
Net Receivables	0.92	0.94	0.92	0.92	0.95	0.95	0.96	-0.27	-0.1	0.99	0.61	0.73	0.76	0.53	0.88	0.84		0.94	0.93	0.88	0.2	0.93	0.92	0.97	0.99	0.61
Common Stock Total Equity	0.82	0.96	0.8	0.8	0.88	0.88	0.87	-0.57	0.18	0.91	0.81	0.57	0.63	0.51	0.87	0.86	0.94		0.9	0.87	-0.06	0.94	0.81	0.95	0.95	0.38
Common Stock Shares Outstanding	0.93	0.95	0.94	0.94	0.95	0.95	0.88	-0.35	0.02	0.93	0.72	0.79	0.87	0.67	0.88	0.77	0.93	0.9		0.88	0.27	0.97	0.94	0.93	0.9	0.66
Long Term Debt Total	0.74	0.95	0.74	0.74	0.78	0.78	0.78	-0.44	0.11	0.87	0.69	0.54	0.79	0.84	1.0	0.73	0.88	0.87	0.88		0.04	0.83	0.74	0.82	0.83	0.41
Non Current Liabilities Total	0.46	0.03	0.49	0.48	0.32	0.33	0.17	0.68	-0.71	0.29	-0.37	0.77	0.61	0.06	0.04	-0.21	0.2	-0.06	0.27	0.04		0.16	0.47	0.14	0.16	0.89
Capital Surpluse	0.94	0.95	0.92	0.92	0.97	0.97	0.87	-0.44	0.03	0.9	0.79	0.75	0.76	0.55	0.83	0.85	0.93	0.94	0.97	0.83	0.16		0.93	0.94	0.93	0.58
Inventory	1.0	0.86	1.0	1.0	0.98	0.99	0.89	-0.08	-0.3	0.92	0.51	0.9	0.85	0.49	0.74	0.74	0.92	0.81	0.94	0.74	0.47	0.93		0.9	0.91	0.82
Other Current Assets	0.89	0.91	0.9	0.9	0.92	0.92	0.97	-0.33	0.06	0.97	0.66	0.69	0.69	0.45	0.82	0.83	0.97	0.95	0.93	0.82	0.14	0.94	0.9		0.96	0.56
Other Stockholder Equity	0.92	0.93	0.9	0.9	0.95	0.95	0.94	-0.31	-0.12	0.96	0.62	0.7	0.69	0.45	0.83	0.86	0.99	0.95	0.9	0.83	0.16	0.93	0.91	0.96		0.57
Total Liab	0.81	0.46	0.83	0.83	0.71	0.72	0.58	0.41	-0.6	0.67	0.02	0.96	0.83	0.3	0.41	0.25	0.61	0.38	0.66	0.41	0.89	0.58	0.82	0.56	0.57

Click cells to compare fundamentals

Inari Medical Account Relationship Matchups

Inari Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	44.5M	214.1M	311.5M	504.2M	674.2M	707.9M
Other Current Liab	6.3M	10.8M	35.2M	47.2M	64.1M	67.3M
Total Current Liabilities	8.9M	13.8M	42.5M	56.2M	76.3M	80.2M
Total Stockholder Equity	(39.1M)	200.3M	239.2M	417.0M	464.9M	488.2M
Net Tangible Assets	(39.1M)	200.3M	239.2M	417.0M	479.6M	503.5M
Property Plant And Equipment Net	3.3M	7.5M	61.4M	72.4M	69.3M	39.4M
Net Debt	(4.2M)	(114.2M)	(63.5M)	(27.9M)	(7.2M)	(7.5M)
Retained Earnings	(41.2M)	(27.4M)	(17.6M)	(46.9M)	(48.5M)	(50.9M)
Accounts Payable	2.5M	3.0M	6.5M	7.7M	10.6M	5.7M
Cash	23.6M	114.2M	92.8M	60.2M	39.2M	64.5M
Non Current Assets Total	5.1M	8.4M	66.3M	81.2M	438.7M	460.6M
Non Currrent Assets Other	1.5M	583K	981K	589K	2.2M	2.3M
Other Assets	1.8M	921K	981K	589K	677.4K	949.3K
Cash And Short Term Investments	23.6M	164.2M	176.1M	326.4M	116.1M	151.8M
Net Receivables	11.3M	28.0M	42.4M	58.6M	70.1M	39.0M
Common Stock Shares Outstanding	48.2M	51.6M	55.6M	52.8M	56.8M	56.8M
Liabilities And Stockholders Equity	44.5M	214.1M	311.5M	504.2M	674.2M	707.9M
Non Current Liabilities Total	74.8M	3.0M	29.8M	31.0M	133.0M	139.6M
Inventory	4.0M	10.6M	21.1M	32.6M	42.9M	45.0M
Other Current Assets	514.1K	2.9M	5.7M	5.3M	6.5M	4.0M
Other Stockholder Equity	2.1M	227.6M	257.1M	462.9M	504.5M	266.9M
Total Liab	83.7M	13.8M	72.3M	87.2M	209.3M	219.8M
Net Invested Capital	(19.7M)	200.3M	239.2M	417.0M	464.9M	233.2M
Property Plant And Equipment Gross	3.3M	7.5M	61.4M	72.4M	83.0M	41.9M
Total Current Assets	39.4M	205.7M	245.2M	422.9M	235.6M	215.4M
Accumulated Other Comprehensive Income	(54.2M)	4K	(402K)	849K	8.9M	9.3M
Capital Stock	6.7K	49K	50K	54K	58K	41.1K
Net Working Capital	30.5M	191.8M	202.7M	366.7M	159.2M	178.7M
Common Stock	6.7K	49K	50K	54K	58K	41.1K
Property Plant Equipment	3.3M	7.5M	16.5M	72.4M	83.2M	87.4M

Currently Active Assets on Macroaxis

TLN	Talen Energy
TMUS	T Mobile
BABA	Alibaba Group Holding
APP	Applovin Corp
VTI	Vanguard Total Stock

When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:

How To Invest In Inari

Details

Is Inari Stock a good investment?

Details

What is Inari Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.

You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.84)

Earnings Share

(1.29)

Revenue Per Share

9.901

Quarterly Revenue Growth

0.214

Return On Assets

(0.03)

The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Inari Selling And Marketing Expenses vs Research Development Analysis

Selling And Marketing Expenses vs Research Development

Selling And Marketing Expenses vs Research Development Correlation Analysis

Correlation Coefficient

Selling And Marketing Expenses

Research Development

Inari Medical fundamental ratios Correlations

Inari Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Inari Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Inventory	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Inventory	+ 1.0	Other Current Liab
Inventory	+ 1.0	Total Current Liabilities
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Long Term Debt Total	+ 1.0	Long Term Debt

Cash	- 0.88	Net Debt
Retained Earnings	- 0.72	Net Debt
Non Current Liabilities Total	- 0.71	Retained Earnings
Total Liab	- 0.6	Retained Earnings
Common Stock Total Equity	- 0.57	Net Debt
Net Debt	- 0.49	Short Long Term Debt Total